Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery

ClinicalTrials.gov ID: NCT01539642

Public ClinicalTrials.gov record NCT01539642. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jun 25, 2026, 7:16 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT01539642
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Talphera, Inc
Industry
Enrollment
172 participants

Conditions and interventions

Interventions

  • Sufentanil NanoTab PCA System/15 mcg Drug
  • Placebo Sufentanil NanoTab PCA System Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2012
Primary completion
Dec 31, 2012
Completion
Jan 31, 2013
Last update posted
Oct 19, 2015

2012 – 2013

United States locations

U.S. sites
12
U.S. states
11
U.S. cities
12
Facility City State ZIP Site status
Surgical Associates of Mobile Mobile Alabama 36607
Caring Clinical Research Corporation Laguna Hills California 92653
The Stamford Hospital Stamford Connecticut 06904
G&G Research Vero Beach Florida 32960
Rush Pain Center Chicago Illinois 60612
CRC of Jackson Jackson Mississippi 39202
Cooper University Hospital Camden New Jersey 08103
Phoenix OB GYN Associates Moorestown New Jersey 08057
New York Methodist Hospital Brooklyn New York 11215
Duke University Medical Center Durham North Carolina 27710
Jefferson Hospital Philadelphia Pennsylvania 19107
Memorial Hermann -Memorial City Medical Center Houston Texas 77024

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01539642, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 19, 2015 · Synced Jun 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01539642 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →